Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
OraPharma
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A minimum of one osseointegrated implant with a diagnosis of peri-implantitis
Absence of any significant oral soft tissue pathology
At least one peri-implant site with an average of 2 probing depth readings between 5mm and 7mm (inclusive) when using a light force and with bleeding on probing within 30 seconds of the probing
Confirmed evidence of pathologic bone loss
At least 1mm of keratinized gingiva present around the implant
You may not be if
Pregnancy
Allergy to tetracycline-class drug(s)
Systemic medical condition(s) requiring antibiotic prophylaxis prior to invasive dental procedures
Presence of active systemic infectious disease such as hepatitis, HIV, history of tuberculosis
Diagnosis of clinically significant or unstable organic disease, or compromised healing potential
Signs of untreated advanced periodontal disease and/or poor oral hygiene
Subjects having a probing depth greater than 8mm at time of enrollment
Subjects presenting with mobility of any dental implant
Subjects having a qualifying implant under occlusal trauma or overloaded (as determined by the investigator)
Clareo Health | Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)
